Skip to main content

J0153 HCPCS Level II Code: Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)

Medicare Coverage & Payment

  • CMS short descriptor: Adenosine inj 1mg
  • Medicare coverage: Special coverage instructions apply (CMS coverage code D)
  • Payment category: Drugs (pricing indicator 51)
  • BETOS: O1E — Other drugs
  • Last CMS action effective: January 1, 2015

Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.

Code Overview

Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) is a HCPCS Level II code (J0153). CMS assigns coverage code D — Special coverage instructions apply. Short description: Adenosine inj 1mg.

Summary composed by MedCoder from this code's official HCPCS Level II record. The tabular instructional notes themselves appear verbatim below.

Change history

  • 2015-01-01
    Added to the code set
    Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)

Drug products (NDC)

CMS ASP NDC-HCPCS Crosswalk · 2026 Q3

Medicare Part B payment limit (ASP + 6%): $0.39

00404-9809-02 Adenosine — Henry Schein Inc. (size 2 × qty 1 (1 MG per billing unit))

00404-9993-02 Adenosine — Henry Schein Inc. (size 2 × qty 1 (1 MG per billing unit))

16714-0556-01 Adenosine — Northstar RxLLC (size 20 × qty 1 (1 MG per billing unit))

16714-0997-01 Adenosine — Northstar RxLLC (size 30 × qty 1 (1 MG per billing unit))

25021-0301-67 Adenosine — Sagent Pharmaceuticals (size 2 × qty 10 (1 MG per billing unit))

25021-0301-68 Adenosine — Sagent Pharmaceuticals (size 4 × qty 10 (1 MG per billing unit))

25021-0318-02 Adenosine — Sagent Pharmaceuticals (size 2 × qty 10 (1 MG per billing unit))

25021-0318-04 Adenosine — Sagent Pharmaceuticals (size 4 × qty 10 (1 MG per billing unit))

51662-1450-01 Adenosine — HF Acquisition Co. LLC, DBA HealthFirst (size 4 × qty 1 (1 MG per billing unit))

51662-1450-03 Adenosine — HF Acquisition Co. LLC, DBA HealthFirst (size 4 × qty 10 (1 MG per billing unit))

51662-1511-01 Adenosine — HF Acquisition Co. LLC, DBA HealthFirst (size 4 × qty 1 (1 MG per billing unit))

51662-1632-01 Adenosine — HF Acquisition Co. LLC, DBA HealthFirst (size 2 × qty 1 (1 MG per billing unit))

51662-1643-03 Adenosine — HF Acquisition Co. LLC, DBA HealthFirst (size 4 × qty 10 (1 MG per billing unit))

55150-0192-01 Adenosine — Eugia US LLC (size 20 × qty 1 (1 MG per billing unit))

55150-0193-01 Adenosine — Eugia US LLC (size 30 × qty 1 (1 MG per billing unit))

63323-0651-02 Adenosine — FreseniUS Kabi USA, LLC (size 2 × qty 10 (1 MG per billing unit))

63323-0651-04 Adenosine — FreseniUS Kabi USA, LLC (size 4 × qty 10 (1 MG per billing unit))

63323-0651-20 Adenosine — FreseniUS Kabi USA, LLC (size 20 × qty 1 (1 MG per billing unit))

63323-0651-30 Adenosine — FreseniUS Kabi USA, LLC (size 30 × qty 1 (1 MG per billing unit))

63323-0651-89 Adenosine — FreseniUS Kabi USA, LLC (size 2 × qty 10 (1 MG per billing unit))

+8 more

Related Codes

Poisoning, adverse-effect and underdosing codes for this drug

The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from the CMS ASP crosswalk and the Table of Drugs and Chemicals, not a CMS-published pairing.

T46.2X1 — Poisoning by other antidysrhythmic drugs, accidental (unintentional), T46.2X2 — Poisoning by other antidysrhythmic drugs, intentional self-harm, T46.2X3 — Poisoning by other antidysrhythmic drugs, assault, T46.2X4 — Poisoning by other antidysrhythmic drugs, undetermined, T46.2X5 — Adverse effect of other antidysrhythmic drugs, T46.2X6 — Underdosing of other antidysrhythmic drugs

From the CMS ASP NDC-HCPCS Crosswalk and Part B Payment Limit File. Payment limits apply per HCPCS billing code, not per package.

Contextual Map

Every relationship of J0153 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

Nearest codes (36)

  • J0120 — Injection, tetracycline, up to 250 mg [Sibling]
  • J0121 — Injection, omadacycline, 1 mg [Sibling]
  • J0122 — Injection, eravacycline, 1 mg [Sibling]
  • J0129 — Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) [Sibling]
  • J0130 — Injection abciximab, 10 mg [Sibling]
  • J0131 — Injection, acetaminophen, not otherwise specified,10 mg [Sibling]
  • J0132 — Injection, acetylcysteine, 100 mg [Sibling]
  • J0133 — Injection, acyclovir, 5 mg [Sibling]
  • and 28 more

Change history

  • 2015-01-01 — Added to the code set [Change history]

Nearest Codes in This Family

Official HCPCS Level II classifications closest to J0153 in its code family, with their registry titles.

  • J0137 — Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg
  • J0138 — Injection, acetaminophen 10 mg and ibuprofen 3 mg
  • J0139 — Injection, adalimumab, 1 mg
  • J0150 — Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)
  • J0151 — Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)
  • J0162 — Injection, epinephrine (fresenius), not therapeutically equivalent to j0165, 0.1 mg
  • J0163 — Injection, epinephrine in sodium chloride (endo), 0.1 mg
  • J0164 — Injection, epinephrine in sodium chloride (baxter), 0.1 mg
  • J0165 — Injection, epinephrine, not otherwise specified, 0.1 mg
  • J0166 — Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mg